Research article
Open Access

Functional and comparative genomics analyses of pmp22 in medaka fish

  • Junji Itou1,
  • Mikita Suyama2,
  • Yukio Imamura3,
  • Tomonori Deguchi4,
  • Kazuhiro Fujimori5,
  • Shunsuke Yuba4,
  • Yutaka Kawarabayasi5 and
  • Takashi Kawasaki5Email author
BMC Neuroscience200910:60

https://doi.org/10.1186/1471-2202-10-60

©  Itou et al; licensee BioMed Central Ltd. 2009

Received: 11 February 2009

Accepted: 17 June 2009

Published: 17 June 2009

Abstract

Background

Pmp22, a member of the junction protein family Claudin/EMP/PMP22, plays an important role in myelin formation. Increase of pmp22 transcription causes peripheral neuropathy, Charcot-Marie-Tooth disease type1A (CMT1A). The pathophysiological phenotype of CMT1A is aberrant axonal myelination which induces a reduction in nerve conduction velocity (NCV). Several CMT1A model rodents have been established by overexpressing pmp22. Thus, it is thought that pmp22 expression must be tightly regulated for correct myelin formation in mammals. Interestingly, the myelin sheath is also present in other jawed vertebrates. The purpose of this study is to analyze the evolutionary conservation of the association between pmp22 transcription level and vertebrate myelin formation, and to find the conserved non-coding sequences for pmp22 regulation by comparative genomics analyses between jawed fishes and mammals.

Results

A transgenic pmp22 over-expression medaka fish line was established. The transgenic fish had approximately one fifth the peripheral NCV values of controls, and aberrant myelination of transgenic fish in the peripheral nerve system (PNS) was observed. We successfully confirmed that medaka fish pmp22 has the same exon-intron structure as mammals, and identified some known conserved regulatory motifs. Furthermore, we found novel conserved sequences in the first intron and 3'UTR.

Conclusion

Medaka fish undergo abnormalities in the PNS when pmp22 transcription increases. This result indicates that an adequate pmp22 transcription level is necessary for correct myelination of jawed vertebrates. Comparison of pmp22 orthologs between distantly related species identifies evolutionary conserved sequences that contribute to precise regulation of pmp22 expression.

Background

Peripheral myelination is important for rapid body movement and sensing several environmental stimuli [1]. The pmp22 gene encodes a hydrophobic tetraspan membrane protein which is a member of the junction protein family Claudin/EMP/PMP22 [2]. In the peripheral nerve system (PNS), PMP22 contributes to the formation and maintenance of the myelin sheath [3, 4]. It is known that in mammals an increase of the pmp22 transcription level induces a reduction in nerve conduction velocity (NCV), coupled with abnormal axonal myelination. In Charcot-Marie-Tooth disease type1A (CMT1A) patients, the majority have a heterozygous tandem duplication of chromosome 17p11.2-p12, a 1.5 Mbp region that includes pmp22, and the patients undergo slow NCV and distal muscle weakness [3, 5]. Thus, pmp22 transcription is likely to be tightly regulated to prevent over-expression. Understanding the regulatory mechanisms of this gene might improve treatment of CMT1A patients.

Promoter regions and some regulatory motifs of mammalian pmp22 have been reported. Transgenic rodent studies have shown the promoter regions and sequence conservation of the gene [6, 7]. Some in vitro studies have identified regulatory motifs for Schwann cell specific expression of pmp22 [8, 9]. However, unidentified functional sequences for modulation of pmp22 expression might be found by comparative genomics analyses.

The comparative genomics approach between jawed fishes and mammals facilitates the identification of novel conserved motifs [10, 11]. Pufferfish, a teleost fish, have a compact genome, which has few redundant non-coding regions and is useful for finding functional sequences [12, 13]. The elephant shark, a cartilaginous fish, has a genome with more conserved sequences with the human genome than the teleost fish genomes, and is expected to assist in the identification of novel essential motifs [14]. Pufferfish and the elephant shark are, however, unsuitable for experimental procedures. Two well known experimental teleost fish, zebrafish and medaka are available for both bioinformatics analyses and laboratory research.

In the present vertebrate phylogeny, the myelin sheath is seen only among jawed vertebrates [1, 15]. It is unclear whether an adequate pmp22 transcription level is necessary for correct myelination in all jawed vertebrates. To address this issue, we established a transgenic medaka fish line overexpressing pmp22 and analyzed aberrations in their PNS. Although zebrafish is more universally used for experiments, we focused on medaka fish [16], because the medaka fish genome has shorter non-coding regions than the zebrafish [17], and thus is advantageous for bioinformatics analyses. Comparative genomics analyses were performed to identify conserved non-coding sequences. Our study reveals that pmp22 has an important role in myelin formation not only in mammals but also in fishes, and shows that the gene structure and some regulatory motifs are conserved among jawed vertebrates.

Results

In silico identification of the pmp22 ortholog in medaka fish

To identify the pmp22 ortholog in medaka fish, a phylogenic tree of the EMP/PMP22 family was drawn based on the amino acid sequence alignment (Figure 1A). The teleost fish genomes, which have undergone another genome duplication compared to other vertebrates [12, 18], have pmp22 paralogs. In medaka fish, two candidate EST sequences for pmp22, including the full length coding regions, are on LG8 and LG19, both of which correspond to human chromosome 17 [19]. The pmp22 cluster that includes mammalian orthologs is clearly separated from the other sequences (bootstrap value, 981). The medaka fish EST sequence AM313848, which maps to the syntenic region of LG19, clustered with mammalian PMP22 sequences. The transmembrane regions, N41 glycosylation site (NXS/T) and C terminus ER-retention/retrieval signal (LRKRE) [20] are conserved in the PMP22 cluster (Figure 1B). This suggests that the gene on LG19 has been conserved as pmp22 in medaka fish (ol_pmp22) and the other gene has been destined for degradation or neo-functionalization. Thus, we focused on the ol_pmp22 candidate encoded on LG19. Ol_pmp22 endogenous transcription was detected in multiple tissues of adult fish (additional file 1).
Figure 1

Sequence conservation of PMP22 in jawed vertebrates. (A) Phylogenic tree of amino acid sequences of the EMP/PMP22 family in jawed vertebrates was drawn by using clustelX and NJ plot. The numbers at the nodes are bootstrap values based on 10,000 replications. Sequences from each subfamily clustered together. The red arrowhead shows the corresponding sequence of ol_pmp22. (B) The amino acid alignment consisting of the mammalian, avian, amphibian, fish pmp22 genes and medaka fish paralogs was drawn by using clustelX and GeneDoc. The white letter on the black background indicates 100 percent conserved blocks. The white letter on the dark gray background indicates 80 percent or greater conserved blocks. The black letter on the bright gray background indicates 60 percent or greater conserved blocks. Red and blue squares indicate conservation of the N41 glycosylation site (NXS/T) and C terminus ER-retention/retrieval signal (LRKRE), respectively. Hs: Homo sapiens (human), Mm: Mus musculus (mouse), Rn: Rattus norvegicus (rat), Gg: Gallus gallus (chicken), Xt: Xenopus tropicalis, Xl: Xenopus laevis, Tn: Tetraodon nigroviridis, Tr: Takifugu rubripes, Ga: Gasterosteus aculeatus (stickleback), Ol: Oryzias latipes (medaka fish), Dr: Danio rerio (zebrafish).

Reduction in peripheral nerve conduction velocity and aberrant myelination in the ol_pmp22 over-expression fish

We constructed a plasmid containing the promoterless FRT flanked EGFP coding sequence with a polyadenylation site. The FLP/FRT recombination system is more active than the Cre/loxP system at approximately 26°C [21], which is a suitable temperature for medaka fish breeding. An 11 kbp fragment containing the region upstream of the ol_pmp22 translation start codon and the FLAG tagged ol_pmp22 coding region with a polyadenylation site were inserted into the promoter and downstream of the FRT flanked region, respectively (additional file 2). This construct was injected into the one-cell stage medaka fish STII (wild type) [22]. We obtained a transgenic fish line with EGFP expression, regulated by the region upstream of the ol_pmp22 translation start codon, (GFP fish). We observed distinct GFP fluorescence from 3 day postfertilization (dpf) (additional file 3). Strong EGFP fluorescence was observed in the boundary region of the midbrain/hindbrain, longitudinal fissure of cerebrum, eye epithelium, olfactory epithelium, spinal cord, gill, liver, kidney, pharynx, intestine, bulbous arteriosus and fin fibroblast in the 10 dpf GFP fish (additional file 3). Though there was a time lag from GFP transcription to fluorescence, the GFP fish fluorescence pattern was consistent with a zebrafish pmp22 study, which was the first report of fish pmp22 [23]. An immunofluorescence study using anti-GFP antibody showed transgene expression in adult Schwann cells, indicating that the 11 kbp region upstream of the ol_pmp22 translation start codon contains sequences for Schwann cell expression (Figure 2). Then, we injected the synthesized flp recombinase mRNA into the one-cell stage GFP fish to remove the FRT flanked region, and established the ol_pmp22 over-expression fish line (pmp22 fish). The transgene, FLAG tagged ol_pmp22, was transcribed in the pmp22 fish, and transcribed at a low level in the GFP fish (Figure 3A). However quantitative RT-PCR showed no significant difference in total ol_pmp22 mRNA levels between the wild type and GFP fish. Compared to the control lines, wild type and GFP fish, the ol_pmp22 transcription level was approximately two-fold higher in the pmp22 fish (Figure 3B).
Figure 2

GFP expression of the transgenic fish in adult Schwann cells. Immunofluorescence staining of adult PNS was performed with a monoclonal antibody to GFP. Adult trunks of wild type (A-C) and transgenic GFP fish (D-F) were sliced horizontally (10 μm). The pictures show bright-field (A, D), fluorescence (B, E), and merged images (C, F). Myelin structures were observed between muscles (white arrow head). Bars: 20 μm.

Figure 3

Relation between pmp22 transcription levels and peripheral NCV, and swimming ability in medaka fish. (A) The transgene, FLAG tagged ol_pmp22, expression in 8dpf fish. RT-PCR was performed with primers to FLAG and the SV40 polyadenylation site. M: 100 bp marker, w: wild type, g: GFP fish, p: pmp22 fish. (B) Relative transcription levels of ol_pmp22 in 8 dpf wild type, GFP fish and pmp22 fish. Beta-actin transcripts were used for an internal control. Relative transcription levels were quantified by defining the wild type average as 1.0 (0.656 to 1.522). Relative quantification of the GFP fish and pmp22 fish was 1.123 (0.898 to 1.405) and 2.056 (1.781 to 2.372), respectively. The minimum and maximum were estimated according to the manufacturer's instructions. Ct: threshold cycle. (**P < 0.05) (C) Population spikes stimulated by 100 μA with or without 1 μM TTX. The large spike is an artifact observed at around 5 seconds (black arrow). The spikes appearing at 6 to 7 seconds, action potential (black arrowhead), were not observed with TTX. (D, F, E) Population spikes of the wild type, D, GFP fish, E, and the pmp22 fish, F. Samples were stimulated with 60 μA. Spikes recorded at two adjacent channels (300 μm distance) were merged. The vertical dashed lines are drawn on each peak time. (G) Peripheral NCV was measured by dividing the distance between two channels by the time lag of the peaks. The peripheral NCV values of wild type, GFP fish and pmp22 fish were 9.566 ± 1.542 m/s, 9.700 ± 1.457 m/s and 1.924 ± 0.738 m/s, respectively (n = 5, **P < 0.05). (H) Flow distance of each line in running water (0.25 m/s). Positions from the start point was recorded every 0.5 seconds (n = 3, *P < 0.1).

To observe the electrical excitability of the fish PNS, population spikes of nerve fibers activated by electrical stimulation were detected in sagittal sections of the adult fish trunk. Activated spikes were not observed with the sodium channel blocker, TTX (1 μM) with 100 μA stimulation, suggesting that the spikes were generated by electrical excitability of neurons (Figure 3C). We observed the peaks of population spikes immediately after 60 μA stimulation and estimated the NCV by the distance between two channels divided by the time lag of the peaks (Figure 3D, E, F). The wild type and GFP fish had similar NCVs (9.566 ± 1.542 m/s, n = 5 and 9.700 ± 1.457 m/s, n = 5, respectively), while the pmp22 fish had approximately one fifth the control line NCV value (1.924 ± 0.738 m/s, n = 5) (Figure 3G).

To test kinematic abnormalities, we observed medaka fish swimming in running water. Medaka fish usually swim against the current to keep their position. However, in a rapid current, the fish were swept downstream while swimming against the current. We measured flow distances of the wild type, GFP fish and pmp22 fish per time in rapid water current (0.25 m/s). The pmp22 fish had a tendency to be swept away faster than the control lines (Figure 3H), indicating that pmp22 over-expression causes weak swimming ability in medaka fish.

From external observations, there were not obvious morphological and developmental abnormalities between the controls and pmp22 fish. However, aberrations were observed in cross sections of pmp22 fish motor nerve fibers by electron microscopy (Figure 4). The pmp22 fish might have undergone hypo- and hypermyelination in the PNS, similar to the mammalian CMT1A phenotype. In the pmp22 fish PNS, almost all observed myelin sheaths were likely to be thin and uncompacted (Figure 4D). We observed abnormal features, which looked like attenuated fibers, in- and outfolding myelin (Figure 4E, F, G), enlarged Schwann cell nuclei (Figure 4B, H, I), bare axons (Figure 4H), wide periaxonal spaces (Figure 4B, K), loose basal laminas (Figure 4B, L), and granules between the nerve fiber and myelin sheath (Figure 4B, K). Furthermore, we observed macrophages near the fibers with myelin debris (Figure 4M, N). These abnormalities were not observed in the wild type PNS. Although the typical onion bulb formation, which is the remarkable feature of demyelinating-remyelinating neuropathies, was not observed in the pmp22 fish, our observations indicate that prevention of pmp22 over-expression is important for keeping fast peripheral NCV and maintaining the myelin sheath in jawed vertebrates.
Figure 4

Electron microscopy observation of cross sections of medaka fish motor nerve fibers. Cross sections of the wild type (A, C) and the pmp22 fish (B, D-N) are shown. The pmp22 fish myelin sheath, D, was thinner than the wild type, C. The attenuated fiber (B; black arrow), enlarged nuclear (B; white arrow, H, I; white arrowhead), large periaxonal space (B, K; white arrowhead), granules (B, K; back arrowhead) and loose basal lamina (B, L; black dashed arrow) were observed in the pmp22 fish PNS. (E) Hypermyelination (black arrowhead) and outfolding (white arrowhead). (F, G) Infolding (black arrowhead). (H) Bare axon (black arrowhead). (I, J) Myelin uncompaction (black arrowhead). (M, N) Myelin debris (black arrowhead) was observed in macrophages. Bars: 2 μm for A and B, 100 nm for C and D, 500 nm for E-N.

Alternative first exons have been conserved in ol_pmp22

Human and rodent pmp22 genes have alternative untranslated first exons, 1A and 1B [24]. Exon1A, located upstream of exon1B, is transcribed in Schwann cells, while the 1B transcript is ubiquitously expressed. In the database, ol_pmp22 EST sequences always have the same first exon. To confirm whether ol_pmp22 has a single first exon or alternative first exons, we constructed the EGFP expression constructs regulated by several regions upstream of the ol_pmp22 translation start codon, and analyzed the EGFP fluorescence patterns by a transient expression assay. The constructs, p11-0, p6.5-0, p3-0, p6.5-3, and p11-5, contain 11 kbp, 6.5 kbp, 3 kbp, 6.5 kbp to 3 kbp followed by 0.5 kbp, and 11 kbp to 5 kbp upstream of the translation start codon, respectively (Figure 5F). The fish injected with p11-0 and p6.5-0 had EGFP fluorescence in morphologically identified Schwann cells [25] and other tissues (Figure 5A, B). Although our transient expression assay was not quantitative, the p11-0 fish had more EGFP expression than the p6.5-0 fish, except in the Schwann cells. The p3-0 fish had no visible EGFP expression in the Schwann cells; however, it had fluorescence in other tissues (Figure 5C). Compared to the p3-0 fish, EGFP expression in the p6.5-3 fish was distinct in Schwann cells, but not in other tissues (Figure 5D). We identified the first exon of the EGFP transcript of the p6.5-3, as the region corresponding to ol_pmp22 exon1A (DDBJ: AB465505). The transcription start site (TSS) of the ol_pmp22 1A transcript is located 5,193 bp upstream of the translation start codon. Then we observed EGFP fluorescence only in Schwann cells of the p11-5 fish (Figure 5E). This finding suggests that the exon-intron structure of pmp22 has been conserved in jawed vertebrates.
Figure 5

GFP fluorescence in the transient expression assay for identification of the alternative first exons. Transgene expression regulated by several constructs containing regions upstream of the translation start codon of ol_pmp22 was observed as GFP fluorescence. (A-E) Dosal view of anterior of fish with the p11-0, p6.5-0, p3-0, p6.5-3 and p11-5 constructs, respectively. White arrowheads show GFP expressing morphologically identified Schwann cells. Bars: 200 μm. (F) The alternative first exons and exon2 of ol_pmp22 and constructs for the transient expression assay.

Primer sets for the detection of 1A, 1B and total ol_pmp22 transcripts were designed. We measured mRNA levels in the whole bodies of 4, 6, 8, 14 and 30 dpf wild type fish (additional file 4). Beta-actin transcripts were detected for an internal control. Each average of 4 dpf ol_pmp22 levels was defined as 1.0 to quantify the relative transcription levels of total, 1A and 1B (Figure 6). The 1A transcript was significantly upregulated in 8 dpf, then decreased in 14 dpf and increased again in 30 dpf. On the other hand, in transient expression assays, the fish with p11-5, lacking the region downstream of exon1A, had no fluorescence until the hatching stage (8–10 dpf), whereas the others, p11, p6.5 and p6.5-3 fish, were visible in the Schwann cell lineage from the embryonic stage (data not shown). These results suggest that the regulatory mechanism of 1A transcription before the hatching stage is different from after hatching, and intron1A contains the region for embryonic stage specific regulation.
Figure 6

Endogenous transcription levels of ol_pmp22 through medaka fish development. Relative transcription levels of total (A), 1A (B) and 1B (C) are shown. Total RNA was prepared from mixed extract of some fish at 4, 6, 8, 14 and 30 dpf, and was used as template for quantitative RT-PCR. Beta-actin transcripts were used for an internal control. Each relative transcription level was quantified by defining the average of 4 dpf transcription level as 1.0. (P < 0.05).

Conserved sequences in the pmp22 region

Some regulatory motifs have already been identified in the promoter regions of human and rodent pmp22 exon1A [8, 24]. NF1 is a conserved non-coding sequence of myelin genes and is located between the TATA-box and the TSS of the pmp22 1A promoter. SREB is the binding site for the sterol regulatory element binding proteins which are transcription factors for cholesterol homeostasis. The FP330 motif B is a conserved regulatory motif in myelin gene promoters. CREB, which is the binding site for the cyclic AMP response element binding protein, has been conserved in several gene promoters in vertebrates [26, 27]. Thus, we analyzed the pmp22 conserved non-coding sequences in jawed vertebrates.

First, in the ol_pmp22 region, we examined the region upstream of exon1A and downstream of the stop codon (DDBJ: AB465503 and DDBJ: AB465504, respectively). We scanned for four known conserved mammalian motifs in the promoter region of ol_pmp22 exon1A by a motif finding program [28]. Although NF1 and SREB were not found, we identified two known regulatory motifs, FP330 motif B and CREB (Figure 7). The FP330 motif B is located immediately upstream of the TSS of human and rodent pmp22 exon1A [24]. The rat Schwannoma cell study revealed that the region around the FP330 motif B is involved with positive regulation of pmp22 1A transcription, and identified the important residues of this motif for DNA-protein interaction (CCAT), located at 3 bp to 6 bp downstream of the motif [9]. The FP330 motif B is also found in the promoter region of ol_pmp22 exon1A (-57 to -46, relative to the TSS of the ol_pmp22 1A transcript), however the important residues are not fully conserved (CAAA), which is the sequence at the corresponding position in mammals. In the promoter region of human pmp22 (hs_pmp22), CREB is identified as the silencer at 1.7 kbp upstream of the 1A TSS [8]. We identified CREB sites at -843 to -836 and -266 to -259 in mouse pmp22 (mm_pmp22) exon1A and ol_pmp22 exon1A, respectively.
Figure 7

Conserved motifs in the promoter region of exon1A of hs_ , mm_ and ol_pmp22. The figure shows the positions of conserved regulatory motifs for pmp22 transcription. The numbers indicate the position relative to each TSS. The hs_ and mm_pmp22 have half of the CREB site (TGAC). The ol_pmp22 has the TG variant of CREB site (TGATGTCA). The position and sequence of the FP330 motif B (CTCTCAGGC) are conserved.

To identify novel conserved non-coding sequences of pmp22 in jawed vertebrates, we performed comparative genomics analyses. Among hs_, mm_ and ol_pmp22, the multiple alignment of genomic sequences revealed some conserved sequences in the non-coding regions (Figure 8). Then, we analyzed these conserved regions in pmp22 of jawed vertebrates. Although, some conserved non-coding regions, located in intron2–4 among hs_, mm_ and ol_pmp22, were not found in other species, the 3'UTR sequence was highly conserved among jawed vertebrates, which includes an mRNA destabilization signal (ATTTA) (Figure 9, 10A). This conserved sequence starts approximately 100 bp to 200 bp downstream of the pmp22 stop codon. Next, we searched for short conserved sequences by a motif finding program [29]. We tried several combinations of the species in each region. One significant sequence pattern was found in intron1A among human, mouse, rat and medaka fish. Because exon1A has only been identified in human, mouse, rat and medaka fish, we searched for this pattern in the upstream region of exon1B in other species. This pattern was significantly conserved in jawed vertebrates, suggesting that the pattern is likely to be functional (Figure 9, 10B).
Figure 8

Multiple alignment of the region of pmp22 in human, mouse and medaka fish. The alignment was performed by LAGAN and presented by VISTA. The x-axis is the ol_pmp22 sequence. The y-axis is conservation from 0% to 100%. Top and bottom panels indicate the conservation of hs_ and mm_pmp22 with ol_pmp22, respectively. Blue and red shades indicate conservation, criteria: 70% or greater identity and minimum length of 20 bp, of transcribed regions (blue) and the other regions (red).

Figure 9

Evolutionary conservation of the pmp22 gene structure and non-coding motifs. The figure shows the structures of exons and conserved non-coding motifs (CREB, FP330, intron1A motif, and 3'UTR motif) of hs_, mm_ and ol_pmp22. Bar: 2000 bp.

Figure 10

Novel identified conserved sequences of pmp22. (A) Highly conserved sequences of the pmp22 3'UTR. The numbers indicate the position from each stop codon. (B) The conserved short sequences in the intron1A region of human, mouse, rat and medaka fish, and in the upstream region of exon1B of chicken, stickleback and zebrafish. The numbers indicate the position from each translation start codon. Sequence conservation is shown under the lines. Hs: Homo sapiens (human), Mm: Mus musculus (mouse), Rn: Rattus norvegicus (rat), Gg: Gallus gallus (chicken), Xt: Xenopus tropicalis, Xl: Xenopus laevis, Tn: Tetraodon nigroviridis, Tr: Takifugu rubripes, Ga: Gasterosteus aculeatus (stickleback), Ol: Oryzias latipes (medaka fish), Dr: Danio rerio (zebrafish).

Discussion

Pmp22 over-expression causes reduction in peripheral NCV and aberrant myelination in jawed vertebrates

Increase of pmp22 expression causes CMT1A in humans and rodents. CMT1A patients, which have a heterozygous tandem duplication of a 1.5 Mbp region that includes hs_pmp22, have reduced peripheral NCV, aberrant myelination and distal muscle atrophy [3, 5]. CMT1A rodent models with pmp22 over-expression, have been established to understand and treat this neuropathy [30–32]. In mouse models with a human YAC containing hs_pmp22, the degree of the CMT1A phenotype depends on the hs_pmp22 transcription level associated with YAC copy number [33, 34]. The C22 mouse, a CMT1A model with 7 YAC copies, shows significant demyelinating neuropathy. A mouse study with tetracycline inducible pmp22 over-expression reveals that demyelination occurs only when pmp22 is highly expressed in adult, and that the neuropathic phenotype is reversible [35]. Rat in vivo and in vitro studies show that progesterone promotes pmp22 1A transcription in Schwann cells [36, 37]. A CMT1A rat model, having 1.6 fold higher pmp22 transcription than wild type rats, is used for the progesterone antagonist test. The progesterone antagonist reduces pmp22 expression level. The treated CMT1A rats show higher motor performance than controls with the relief of muscle atrophy and sciatic nerve demyelination [38]. Ascorbic acid improves the CMT1A phenotype through the inhibition of cyclic AMP stimulation of pmp22 transcription. The ascorbic acid treated C22 mice have more activity, correct myelination and a longer life span than control neuropathy mice [39]. The principles of these treatments are based on the reduction of pmp22 transcription. Recently, another approach for the treatment of this neuropathy has been reported. In the C22 Schwann cells, there are large aggresomes, including PMP22 and ubiquitin, at perinuclear regions [40]. Also, the HSP90 inhibitor promotes heat shock protein expression, and corrects Schwann cell myelination with clearance of aggregated PMP22 [41].

The myelin sheath enables saltatory conduction in animals [1]. The jawed vertebrates have myelinated axons and conserved pmp22. To analyze the relationship between pmp22 transcription level and peripheral myelination in medaka fish, pmp22 fish were established. Compared with control lines, ol_pmp22 overexpressing fish, having approximately two-fold higher transcription of ol_pmp22, have one fifth peripheral NCV and aberrant PNS myelination, in spite of the transgene lacking intron 2–4 and the region downstream of the coding regions (Figure 3, 4). CMT1A patients and rodent models have hypo- and hypermyelination, attenuated fibers and onion bulb formations in the PNS [3, 32]. In PNS, PMP22 interacts with α6β4 integrin to stabilize the attachment between the basal lamina and myelin sheath [42]. The β4 integrin and distroglycan double knockout mice lose myelin sheath stability with loose basal laminas and macrophage infiltration [43]. The macrophage-mediated myelin disruption occurs in human CMT1A with the pmp22 duplication [44], the C61 mouse with 4 YAC copies [45], the myelin glycoprotein P0 heterozygous deficient mouse [46], and the gap junction protein CX32 null mouse [47]. P0 and CX32 contribute to myelin formation in PNS [4]. Similar to these phenotypes observed in the PNS in mammals, we found loose basal laminas and macrophages including myelin debris in the PNS of pmp22 fish (Figure 4). Therefore our observations of the pmp22 fish suggest that the association of pmp22 expression levels with myelin maintenance is common among jawed vertebrates. Although, the pmp22 fish have normal growth, feeding and mating throughout life in the laboratory, it seems that prevention of pmp22 over-expression provides some advantages for selective pressure because of reduced NCV, weak swimming ability against the current and aberrant myelination caused by pmp22 over-expression in medaka fish.

The exon-intron structure and non-coding motifs of pmp22 are conserved

The PMP22 sequence is highly conserved in jawed vertebrates, but less so in the chordate [48]. Alignments show that there are many conserved non-coding regions among mammals, and some regions in jawed vertebrates. Human and rodent pmp22 consist of alternative untranslated first exons, 1A and 1B [24], and four coding exons. Mammalian exon1A, located upstream of exon1B, is specifically expressed in Schwann cells. The alternative first exons also exist in ol_pmp22, suggesting that the common ancestor of teleost fishes and mammals had these exons, and the gene structure has been conserved in present jawed vertebrates. The ol_pmp22 1A transcript was upregulated in near hatching stage fish (Figure 6), which have immature Schwann cells with radial sorting in correspondence with zebrafish and rodent development [25, 49–51]. Radial sorting is a step for differentiation from immature Schwann cells into myelinating Schwann cells. In this step, immature Schwann cells establish a 1:1 relationship with axons. On the other hand, as well as the rodent pmp22 1A transcript, which is elevated during myelination after birth [24, 52], ol_pmp22 1A transcription increased after hatching (Figure 6). These results suggest that there is similar temporal expression of pmp22 1A transcription among jawed vertebrates.

Our bioinformatics analyses found that ol_pmp22 has two known conserved regulatory motifs (Figure 7). The FP330 motif B (CTCTCAGGC) is conserved immediately upstream of the TSS of pmp22 exon1A [9, 24]. This motif is found in promoters of essential myelin genes in mammals. While in the promoter region of hs_pmp22 exon1A, a CREB half-site (TGAC) has been identified as the silencer responding to low cyclic AMP levels [8]. A CREB half-site and CREB TG variant (TGATGTCA) [27] were found in the mm_ and ol_pmp22 exon1A promoter region, respectively. However, it is unclear whether both of these CREB sites are functional.

In mammalian Schwann cells, pmp22 1A transcription is activated by the zinc finger transcription factor EGR2, which is the major positive regulator for essential myelin genes [53]. The direct target genes of EGR2 are p0, mbp, mag, prx and dhh, but not pmp22 [54, 55]. In the ol_pmp22 region, the EGR2 binding motif was not found in our analyses. In a transgenic mouse study, over-expression of POU-domain protein POU3f1 downregulates pmp22 transcription [56]. There are many candidate sequences for POU3f1 binding in the promoter region of ol_pmp22 (data not shown); however it is unknown which sites are functional. MicroRNAs miR-9 and miR-29a inhibit pmp22 translation [57, 58]. The binding sequences for miR-9 and miR-29a are conserved among human, rodent and chicken pmp22, but not among amphibian and jawed fish pmp22.

Furthermore, in this study, two additional conserved sequences were found. The pmp22 gene has highly conserved sequence in the 3'UTR, the length of which is about 70 bp, and includes an mRNA destabilization signal (Figure 10A). This 3'UTR sequence is unique in the genome. It is possible that the 3'UTR conservation contributes to modulating the PMP22 level by transcriptional or posttranscriptional regulation. By using a motif finding program, the novel conserved short sequence was found in intron1A of human, rodent and medaka fish pmp22 and in the upstream region of exon1B of the other species pmp22 (Figure 10B). In our transient expression assay, fish having the GFP expression construct, lacking the region downstream of exon1A, had no fluorescence until the hatching stage. These results suggest that the regulatory mechanism of 1A transcription in the embryonic stage is different from that after the hatching stage, and that this novel motif must be responsible for the embryonic stage expression of pmp22.

The DNA-binding domains of several transcription factors and short DNA sequences for transcription factor binding are usually conserved in animal genomes [59, 60]. Comparison of the corresponding genome regions between fishes and mammals is useful for identification of functionally conserved sequences. We have successfully found novel conserved non-coding motifs (Figure 10), however further studies are necessary to fully understand pmp22 expression.

Conclusion

We investigated the relation of pmp22 transcription level with PNS pathophysiology in medaka fish. Similar to the mammalian CMT1A phenotype caused by pmp22 over-expression, reduction in peripheral NCV and aberrant myelin formation were observed in the pmp22 over-expression fish, having two fold higher transcription of ol_pmp22. These results suggest that the contribution of adequate pmp22 expression in PNS is common among jawed vertebrates. Moreover, we elucidated the structural conservation of the gene among human, rodent and medaka fish, and found novel conserved non-coding motifs. These results indicate that the common ancestor for jawed vertebrates had acquired myelin formation with the associated gene functions including pmp22 and it has been conserved in present species.

Methods

Medaka fish breeding and selection

All fish lines were maintained at around 26°C under a 14 h light and 10 h dark cycle. Collected eggs were grown with 0.3% sea salt water. GFP transgenic fish were screened by fluorescent microscopy observation at embryonic and juvenile stages. Genotyping to select pmp22 over-expression fish was performed by PCR amplification of tail fin genomic DNA using primers ip166 (5'-CATGGATTACAAAGACGACGA-3') and ip167 (5'-ATGAGTCCGCTGATGAGCAC-3'). Manipulation of fish was performed following both national and institutional guidelines.

DNA, RNA preparation and cDNA synthesis

Fish genomic DNA was prepared by phenol-chloroform and ethanol precipitation. Plasmids were prepared with the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). Total RNA was extracted by ISOGEN (Nippongene, Tokyo, Japan). First strand cDNA was synthesized by using the First-Strand cDNA Synthesis Kit (GE Healthcare, Tokyo, Japan).

DNA construction

To construct the EGFP basic vector, an NcoI/XbaI digested EGFP coding fragment was obtained from a pEGFP vector (Clontech, Palo Alto, CA, USA) and inserted into the NcoI/XbaI digested pGL3-basic vector (Promega, Madison, WI, USA).

The 11 kbp region upstream of the translation start codon of ol_pmp22 was amplified by PCR with HdrR genomic DNA as the template and primers ip097 (5'-ATACGCGTATCATTTTCAAGGTCACTGGG-3') and ip098 (5'-AAGGATCCTTCACGGCCAGTCTAAGAAGAGAGGAGACA-3'). To construct the p11-0 EGFP expression vector, the amplified 11 kbp DNA fragment was digested with MluI/BamHI, and inserted into the MluI/BglII digested EGFP basic vector. The amplified 11 kbp DNA was digested with BamHI and partially digested with BglII, to obtain 6.5-0, 3-0 and 6.5-3 fragments. To construct the p6.5-0 and p3-0 vector, the fragments were inserted into the BglII digested and BAP treated EGFP basic vector. The 0.5 kbp fragment including the splice accepter sequence was obtained by PCR amplification of genomic DNA using primers ip119 (5'-TAAGATCTCTTTGCTCTGGGTTAAAGTT-3') and ip098, digested with BglII/BamHI and inserted into the BglII digested and BAP treated EGFP basic vector. To construct the p6.5-3 EGFP expression vector, the 6.5-3 fragment was inserted into the BglII digested and BAP treated EGFP vector containing the 0.5 kbp region upstream of the translation start codon. To construct p11-5, the 6 kbp fragment including ol_pmp22 exon1A and its upstream region was obtained by PCR amplification of genomic DNA using primer ip097 and ip134 (5'-TTTGGATCCAGTGAGGCTCTACCTGCTCG-3'), digested with MluI/BamH I and inserted into MluI/BglII digested EGFP basic vector.

The FRT flanked EGFP-BGHp(A) – FLAG-ol_pmp22 vector was constructed for establishing the pmp22 over-expression line. The FLAG-ol_pmp22 fragment was obtained by RT-PCR of medaka 8 dpf whole embryos using primers ip017 (5'-CCATGGATTACAAAGACGACGACGACAAAATGCTGATCTTA-3') and ip018 (5'-TCTAGATCATTCTCGCTTCCT-3'). The PCR product was digested with NcoI/XbaI and inserted into the NcoI/XbaI digested pGL3-basic vector. The fragment of BGHp(A) was amplified by PCR with phrGFPII-1 (Stratagene, La Jolla, CA, USA) as template and primers ip041 (5'-GGTCTAGATTCCCTTTAGTGAG-3') and ip042 (5'-GCGGATCCGGCGCCCCAGCATG-3'), digested with XbaI/BamHI and inserted into the XbaI/BamHI digested EGFP basic vector. To construct the FRT-flanked EGFP-BGHp(A) vector, the fragment was obtained by PCR amplification with the EGFP-BGHp(A) vector as template and primers ip044 (5'-CGAGATCTGAAGTTCCTATTCCGAAGTTCCTATTCTCTA GAAAGTATAGGAACTTCAAGCTTGGCATTCCGGTACTG-3') and ip045 (5'-AGAGCGCTCGAGGGCCCGTCTCCCATGAAGTTCCTATACTTTCTAGAGAA TAGGAACTTCGGAATAGGAACTTCGAATTCCGACGATAGTCATGCCC-3'), digested with BglII/Eco47III and inserted into the BglII/Eco47III digested pGL3-basic vector. An NcoI/Eco47III digested FLAG-ol_pmp22 fragment was obtained, and it was inserted into the BsmBI/Eco47III digested FRT-flanked EGFP-BGHp(A) vector. This vector was digested with MluI/BglII and ligated with the MluI/BamHI digested 11 kbp PCR product of the region upstream of the translation start codon (see additional file 2, the plasmid construct was drawn with PlasMapper [61]).

Microinjection

Medaka fish fertilized eggs were collected immediately after spawning and placed into cold Yamamoto's solution (133 mM NaCl, 2.7 mM KCl, 2.1 mM CaCl2, 0.2 mM NaHCO3, pH 7.3). The solution (0.1 M K3PO4, 0.05% phenol red) with either plasmid DNA (30 ng/μl) or mRNA (400 ng/μl) was injected into the cytoplasm of one – cell stage eggs through the chorion. For in vitro capped mRNA synthesis, template DNA including the T7 promoter and FLP recombinase coding sequence were amplified by PCR with pOG44 as template and primers ip131 (5'-ATTAATACGACTCACTATAGGGCTCTCCACAGGTGTCCACTC-3') and ip132 (5'-ACCCGCACATACAGCTCACT-3'). Flp mRNA was synthesized by using the mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX, USA) and polyadenylated by the Poly (A) Tailing kit (Ambion). A pressure injector, FemtoJet (Eppendorf, Hamburg, Germany), was used with borosilicate glass capillaries GC100F-10 (Harvard Apparatus, Kent, UK).

Immunofluorescence

Adult trunks were removed along with the bones and fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) (pH 7.4) at 4°C for several hours. Fixed samples were decalcificated by 6% sucrose at 4°C overnight. Infiltration and embedding in glycol methacrylate were performed with Technovit 8100 (Heraeus Kulzer, Werheim, Germany). Embedded samples were sliced horizontally (10 μm) by a rotary microtome, Leica RM2165 (Leica, Nussloch, Germany) equipped with a disposable microtome blade N35 (Feather, Osaka, Japan), stretched with distilled water on slide glasses, and dried at room temperature (RT) overnight. After soaking with PBS, samples were incubated with 0.1 mg/ml proteinase K at 37°C for 15 min, rinsed with PBS, incubated with blocking solution (1% horse serum in PBS with 0.5% Tween 20) at RT for 1 h, incubated with 1/500 anti-GFP monoclonal antibody (Nacalai tesque, Kyoto, Japan) in blocking solution at 4°C overnight, rinsed with PBS with 0.5% Tween 20, incubated with 1/500 Alexa fluor 488 conjugated anti-mouse IgG antibody (Invitrogen, Eugene, OR, USA) in blocking solution at RT for 1 h, and rinsed with PBS. Bright-field and fluorescence images were observed using a confocal microscope FV1000 (Olympus, Tokyo, Japan) and data were obtained by Fluoview ver 1.6b software (Olympus).

5'-RACE

Total RNA was prepared from whole bodies of p6.5-3 injected fish at 14 dpf. The SMART RACE cDNA Amplification kit (Clontech) and SuperScript II Reverse Transcriptase (Invitrogen) were used for first strand cDNA synthesis. RACE PCR was performed by using the Advantage 2 PCR kit (Clontech) with primer ip128 (5'-TAGGTCAGGGTGGTCACGAGGGT-3').

Quantitative RT-PCR

The target mRNA quantification was performed by using the Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The following primers were used: ip150 (5'-GCTCTCTGATGATTCTTGCTTTTG-3') and ip151 (5'-AGGAGCAGAATGTCCAGAATGC-3') for the 1A transcript, ip152 (5'-CTACTGCAGGTCCACTCTTTTGG-3') and ip153 (5'-GGCCAGTTTCAAGCAAATCG-3') for the 1B transcript, ip160 (5'-TCCTCTTCTTCTGTCAGCTCTTCA-3') and ip161 (5'-GCTCCGCTCATCACAAACAA-3') for total ol_pmp22 transcript, ip154 (5'-GCCCCACCAGAGCGTAAATAC-3') and ip155 (5'-CATCGTACTCCTGCTTGCTGAT-3') for beta-actin[62]. Relative quantification was calculated according to the manufacturer's instructions.

Electrophysiology

The electrical excitability of fish nerve was measured according to Imamura Y., 2008 [63]. Sagittal fish slices (500 μm) were cut by a vibrating microtome, DTK-1000 (DSK, Kyoto, Japan) in an oxygenated (95% O2/5% CO2) physiological solution, artificial cerebrospinal fluid (ACSF) at 4°C, containing: 126 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 26 mM NaHCO3, 1,25 mM NaH2PO4, 2 mM CaCl2 and 10 mM D-glucose. The sample was attached to a 64 channel-electrode dish perfused with ACSF (3 ml/min). Peripheral nerve fibers were stimulated with 0.1 Hz, 60 or 100 μA, and population spikes of fish nerve fibers at 300 μm, 600 μm, and 900 μm distance between two channels were recorded in the perfusion of ACSF. The recording was stored in Windows XP hardware and data analysis was performed with Mobius software of the MED64 system (Alpha MED Sciences, Osaka, Japan). Statistical analysis was performed by Student's t-test.

Swimming ability test

The medaka fish swimming ability test was performed in running water (0.25 m/s) in a straight horizontal watercourse (depth 30 mm, width 70 mm, length 1 m) at room temperature. Adult male fish were used. The volume of water flow from a 15 mm diameter hose was 188 ml per second. Medaka fish were put into a decelerated water current in a net for 30 seconds and gently released into the rapid water current. The movie of a top view of fish swimming was acquired by a digital video camera, NV-GS250-S (Matsushita, Osaka, Japan). A picture of each time point was obtained by MotionDV STUDIO 5.3J LE for DV software (Matsushita), and analyzed by the scion image software (Scion, Frederick, MD, USA). Statistical analysis was performed by Student's t-test.

Electron microscopy

Adult trunks were removed along with the bones and cut into 1–2 mm pieces. Samples were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h, washed in 0.1 M phosphate buffer (pH 7.4) for 20 min 5 times and postfixed in 1% OsO4 in phosphate buffer (pH 7.4) for 2 h. Then samples were dehydrated: 50% ethanol for 10 min, 60% ethanol for 10 min, 70% ethanol for 10 min, 80% ethanol for 10 min, 90% ethanol for 10 min, 99% ethanol for 10 min and 100% ethanol for 20 min twice. Dehydrated samples were transferred to propylene-oxide for 20 min twice, 1:1 propylene-oxide:epoxyresin for 1 h, 1:3 propylene-oxide:epoxyresin for 1 h and epoxyresin overnight. For embedding, samples were left at 60°C with fresh epoxyresin three overnight. Ultra thin sections (80 nm) were obtained on an Ultra microtome EM UC6 (Leica, Vienna, Austria), counterstained by Reynolds method and examined on an H-7650 (Hitachi, Tokyo, Japan). Medaka fish motor nerve fibers were determined on the locations according to the studies for zebrafish motor nerve fibers [64, 65].

Bioinformatics analysis

Sequences of the EMP/PMP22 family were obtained by BLAST and BLAT, using human amino acid sequences of the family as the queries. For phylogenic analysis, mRNA sequences were translated into amino acid sequences. The analyses for conserved motifs were performed by the scan for matches [28], Weeder [29] and jasper [66]. Multiple alignment of pmp22 was performed by LAGAN [67] and presented by VISTA [68].

List of abbreviations

pmp22 : 

peripheral myelin protein 22

CMT1A: 

Charcot-Marie-Tooth disease type1A

NCV: 

nerve conduction velocity

PNS: 

peripheral nerve system

EMP: 

epithelial membrane protein

UTR: 

untranslated region

LG: 

linkage group

FRT: 

FLP recognition target

EGFP: 

enhanced green fluorescent protein

dpf: 

day postfertilization

TTX: 

tetrodotoxin

EST: 

expression sequence tags

TSS: 

transcription start site

CREB: 

cyclic AMP response element binding

YAC: 

yeast artificial chromosome

ACSF: 

artificial cerebrospinal fluid

PCR: 

polymerase chain reaction.

Declarations

Acknowledgements

We would like to thank Dr Junya Kobayashi, Dr Kenshi Komatsu and Dr Makoto Noda for technical advice and discussion. The electron microscopy study was supported by the Laboratory of Electron Microscopy, Center for Anatomical Studies, Graduate School of Medicine, Kyoto University. This work was supported by Ministry of Economy, Trade and Industry of Japan, and Grants-in-Aid for Scientific Research on Priority Areas "Comparative Genomics" from Ministry of Education, Culture, Sports, Science and Technology of Japan. Sequence data were obtained from INSD (DDBJ/EMBL/GenBank) and the UCSC Genome Browser http://genome.ucsc.edu/.

Authors’ Affiliations

(1)
Department of Radiation Biomedical Science IV, Radiation Biology Center, Graduate School of Medicine, Kyoto University
(2)
Department of Genome Informatics, Center for Genomic Medicine, Graduate School of Medicine, Kyoto University
(3)
Department of Molecular Oncology, Graduate School of Medicine, Kyoto University
(4)
Tissue Engineering Research Group, Research Institute for Cell Engineering, National Institute of Advanced Industrial Science and Technology (AIST)
(5)
Genome Intelligence Research Group, Research Institute for Cell Engineering, National Institute of Advanced Industrial Science and Technology (AIST)

References

  1. Hartline DK, Colman DR: Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol. 2007, 17 (1): R29-35. 10.1016/j.cub.2006.11.042.View ArticlePubMedGoogle Scholar
  2. Ben-Porath I, Kozak CA, Benvenisty N: Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics. 1998, 49 (3): 443-447. 10.1006/geno.1998.5238.View ArticlePubMedGoogle Scholar
  3. Young P, Suter U: The causes of Charcot-Marie-Tooth disease. Cell Mol Life Sci. 2003, 60 (12): 2547-2560. 10.1007/s00018-003-3133-5.View ArticlePubMedGoogle Scholar
  4. Berger P, Niemann A, Suter U: Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia. 2006, 54 (4): 243-257. 10.1002/glia.20386.View ArticlePubMedGoogle Scholar
  5. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P: Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 1997, 120 (Pt 5): 813-823. 10.1093/brain/120.5.813.View ArticlePubMedGoogle Scholar
  6. Maier M, Castagner F, Berger P, Suter U: Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Mol Cell Neurosci. 2003, 24 (3): 803-817. 10.1016/S1044-7431(03)00246-X.View ArticlePubMedGoogle Scholar
  7. Orfali W, Nicholson RN, Guiot MC, Peterson AC, Snipes GJ: An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration. J Neurosci Res. 2005, 80 (1): 37-46. 10.1002/jnr.20425.View ArticlePubMedGoogle Scholar
  8. Saberan-Djoneidi D, Sanguedolce V, Assouline Z, Levy N, Passage E, Fontes M: Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene. 2000, 248 (1–2): 223-231. 10.1016/S0378-1119(00)00116-5.View ArticlePubMedGoogle Scholar
  9. Hai M, Bidichandani SI, Patel PI: Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J Neurosci Res. 2001, 65 (6): 508-519. 10.1002/jnr.1181.View ArticlePubMedGoogle Scholar
  10. Muller F, Blader P, Strahle U: Search for enhancers: teleost models in comparative genomic and transgenic analysis of cis regulatory elements. Bioessays. 2002, 24 (6): 564-572. 10.1002/bies.10096.View ArticlePubMedGoogle Scholar
  11. Woolfe A, Goodson M, Goode DK, Snell P, McEwen GK, Vavouri T, Smith SF, North P, Callaway H, Kelly K, et al.: Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol. 2005, 3 (1): e7-10.1371/journal.pbio.0030007.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Christoffels A, Koh EG, Chia JM, Brenner S, Aparicio S, Venkatesh B: Fugu genome analysis provides evidence for a whole-genome duplication early during the evolution of ray-finned fishes. Mol Biol Evol. 2004, 21 (6): 1146-1151. 10.1093/molbev/msh114.View ArticlePubMedGoogle Scholar
  13. Ovcharenko I, Stubbs L, Loots GG: Interpreting mammalian evolution using Fugu genome comparisons. Genomics. 2004, 84 (5): 890-895. 10.1016/j.ygeno.2004.07.011.View ArticlePubMedGoogle Scholar
  14. Venkatesh B, Kirkness EF, Loh YH, Halpern AL, Lee AP, Johnson J, Dandona N, Viswanathan LD, Tay A, Venter JC, et al.: Ancient noncoding elements conserved in the human genome. Science. 2006, 314 (5807): 1892-10.1126/science.1130708.View ArticlePubMedGoogle Scholar
  15. Bullock TH, Moore JK, Fields RD: Evolution of myelin sheaths: both lamprey and hagfish lack myelin. Neurosci Lett. 1984, 48 (2): 145-148. 10.1016/0304-3940(84)90010-7.View ArticlePubMedGoogle Scholar
  16. Wittbrodt J, Shima A, Schartl M: Medaka–a model organism from the far East. Nat Rev Genet. 2002, 3 (1): 53-64. 10.1038/nrg704.View ArticlePubMedGoogle Scholar
  17. Takeda H: Draft genome of the medaka fish: a comprehensive resource for medaka developmental genetics and vertebrate evolutionary biology. Dev Growth Differ. 2008, 50 (Suppl 1): S157-166.View ArticlePubMedGoogle Scholar
  18. Vandepoele K, De Vos W, Taylor JS, Meyer A, Peer Van de Y: Major events in the genome evolution of vertebrates: paranome age and size differ considerably between ray-finned fishes and land vertebrates. Proc Natl Acad Sci USA. 2004, 101 (6): 1638-1643. 10.1073/pnas.0307968100.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Postlethwait J, Amores A, Cresko W, Singer A, Yan YL: Subfunction partitioning, the teleost radiation and the annotation of the human genome. Trends Genet. 2004, 20 (10): 481-490. 10.1016/j.tig.2004.08.001.View ArticlePubMedGoogle Scholar
  20. Naef R, Suter U: Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech. 1998, 41 (5): 359-371. 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
  21. Buchholz F, Ringrose L, Angrand PO, Rossi F, Stewart AF: Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 1996, 24 (21): 4256-4262. 10.1093/nar/24.21.4256.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Wakamatsu Y, Pristyazhnyuk S, Kinoshita M, Tanaka M, Ozato K: The see-through medaka: a fish model that is transparent throughout life. Proc Natl Acad Sci USA. 2001, 98 (18): 10046-10050. 10.1073/pnas.181204298.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Wulf P, Bernhardt RR, Suter U: Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res. 1999, 57 (4): 467-478. 10.1002/(SICI)1097-4547(19990815)57:4<467::AID-JNR6>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
  24. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem. 1994, 269 (41): 25795-25808.PubMedGoogle Scholar
  25. Yoshida M, Macklin WB: Oligodendrocyte development and myelination in GFP-transgenic zebrafish. J Neurosci Res. 2005, 81 (1): 1-8. 10.1002/jnr.20516.View ArticlePubMedGoogle Scholar
  26. Mayr B, Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001, 2 (8): 599-609. 10.1038/35085068.View ArticlePubMedGoogle Scholar
  27. Smith B, Fang H, Pan Y, Walker PR, Famili AF, Sikorska M: Evolution of motif variants and positional bias of the cyclic-AMP response element. BMC Evol Biol. 2007, 7 (Suppl 1): S15-10.1186/1471-2148-7-S1-S15.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Dsouza M, Larsen N, Overbeek R: Searching for patterns in genomic data. Trends Genet. 1997, 13 (12): 497-498. 10.1016/S0168-9525(97)01347-4.View ArticlePubMedGoogle Scholar
  29. Pavesi G, Mereghetti P, Zambelli F, Stefani M, Mauri G, Pesole G: MoD Tools: regulatory motif discovery in nucleotide sequences from co-regulated or homologous genes. Nucleic Acids Res. 2006, W566-570. 10.1093/nar/gkl285. 34 Web ServerGoogle Scholar
  30. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U: Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci. 1996, 16 (17): 5351-5360.PubMedGoogle Scholar
  31. Meyer Zu Horste G, Nave KA: Animal models of inherited neuropathies. Curr Opin Neurol. 2006, 19 (5): 464-473.View ArticlePubMedGoogle Scholar
  32. Sereda MW, Nave KA: Animal models of Charcot-Marie-Tooth disease type 1A. Neuromolecular Med. 2006, 8 (1–2): 205-216. 10.1385/NMM:8:1:205.View ArticlePubMedGoogle Scholar
  33. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M: Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet. 1996, 5 (5): 563-569. 10.1093/hmg/5.5.563.View ArticlePubMedGoogle Scholar
  34. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, et al.: Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet. 1998, 7 (3): 449-458. 10.1093/hmg/7.3.449.View ArticlePubMedGoogle Scholar
  35. Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C: Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet. 2001, 10 (10): 1007-1018. 10.1093/hmg/10.10.1007.View ArticlePubMedGoogle Scholar
  36. Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, Schumacher M: Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem. 1998, 71 (4): 1765-1768.View ArticlePubMedGoogle Scholar
  37. Melcangi RC, Magnaghi V, Cavarretta I, Zucchi I, Bovolin P, D'Urso D, Martini L: Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res. 1999, 56 (4): 349-357. 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
  38. Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003, 9 (12): 1533-1537. 10.1038/nm957.View ArticlePubMedGoogle Scholar
  39. Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004, 10 (4): 396-401. 10.1038/nm1023.View ArticlePubMedGoogle Scholar
  40. Fortun J, Go JC, Li J, Amici SA, Dunn WA, Notterpek L: Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis. 2006, 22 (1): 153-164. 10.1016/j.nbd.2005.10.010.View ArticlePubMedGoogle Scholar
  41. Rangaraju S, Madorsky I, Pileggi JG, Kamal A, Notterpek L: Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol Dis. 2008, 32 (1): 105-115. 10.1016/j.nbd.2008.06.015.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Amici SA, Dunn WA, Murphy AJ, Adams NC, Gale NW, Valenzuela DM, Yancopoulos GD, Notterpek L: Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci. 2006, 26 (4): 1179-1189. 10.1523/JNEUROSCI.2618-05.2006.View ArticlePubMedGoogle Scholar
  43. Nodari A, Previtali SC, Dati G, Occhi S, Court FA, Colombelli C, Zambroni D, Dina G, Del Carro U, Campbell KP, et al.: Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci. 2008, 28 (26): 6714-6719. 10.1523/JNEUROSCI.0326-08.2008.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Vital A, Vital C, Lagueny A, Ferrer X, Ribiere-Bachelier C, Latour P, Petry KG: Inflammatory demyelination in a patient with CMT1A. Muscle Nerve. 2003, 28 (3): 373-376. 10.1002/mus.10404.View ArticlePubMedGoogle Scholar
  45. Kobsar I, Hasenpusch-Theil K, Wessig C, Muller HW, Martini R: Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J Neurosci Res. 2005, 81 (6): 857-864. 10.1002/jnr.20601.View ArticlePubMedGoogle Scholar
  46. Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R: The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol. 2001, 152 (2): 301-308. 10.1083/jcb.152.2.301.PubMed CentralView ArticlePubMedGoogle Scholar
  47. Kobsar I, Maurer M, Ott T, Martini R: Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci Lett. 2002, 320 (1–2): 17-20. 10.1016/S0304-3940(02)00015-0.View ArticlePubMedGoogle Scholar
  48. Gould RM, Morrison HG, Gilland E, Campbell RK: Myelin tetraspan family proteins but no non-tetraspan family proteins are present in the ascidian (Ciona intestinalis) genome. Biol Bull. 2005, 209 (1): 49-66. 10.2307/3593141.View ArticlePubMedGoogle Scholar
  49. Jessen KR, Mirsky R: Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 1999, 22 (9): 402-410. 10.1016/S0166-2236(98)01391-5.View ArticlePubMedGoogle Scholar
  50. Buchstaller J, Sommer L, Bodmer M, Hoffmann R, Suter U, Mantei N: Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J Neurosci. 2004, 24 (10): 2357-2365. 10.1523/JNEUROSCI.4083-03.2004.View ArticlePubMedGoogle Scholar
  51. Woodhoo A, Sommer L: Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia. 2008, 56 (14): 1481-1490. 10.1002/glia.20723.View ArticlePubMedGoogle Scholar
  52. Maier M, Berger P, Nave KA, Suter U: Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci. 2002, 20 (1): 93-109. 10.1006/mcne.2002.1116.View ArticlePubMedGoogle Scholar
  53. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J: EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron. 2001, 30 (2): 355-368. 10.1016/S0896-6273(01)00282-3.View ArticlePubMedGoogle Scholar
  54. Jang SW, LeBlanc SE, Roopra A, Wrabetz L, Svaren J: In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J Neurochem. 2006, 98 (5): 1678-1687. 10.1111/j.1471-4159.2006.04069.x.View ArticlePubMedGoogle Scholar
  55. Jones EA, Jang SW, Mager GM, Chang LW, Srinivasan R, Gokey NG, Ward RM, Nagarajan R, Svaren J: Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 2007, 3 (4): 377-387. 10.1017/S1740925X08000173.PubMed CentralView ArticlePubMedGoogle Scholar
  56. Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, Milbrandt J: Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J Neurosci. 2007, 27 (43): 11552-11559. 10.1523/JNEUROSCI.5497-06.2007.View ArticlePubMedGoogle Scholar
  57. Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD: Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci. 2008, 28 (45): 11720-11730. 10.1523/JNEUROSCI.1932-08.2008.PubMed CentralView ArticlePubMedGoogle Scholar
  58. Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L: Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia. 2009.Google Scholar
  59. Elgar G, Vavouri T: Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet. 2008, 24 (7): 344-352. 10.1016/j.tig.2008.04.005.View ArticlePubMedGoogle Scholar
  60. Copley RR: The animal in the genome: comparative genomics and evolution. Philos Trans R Soc Lond B Biol Sci. 2008, 363 (1496): 1453-1461. 10.1098/rstb.2007.2235.PubMed CentralView ArticlePubMedGoogle Scholar
  61. Dong X, Stothard P, Forsythe IJ, Wishart DS: PlasMapper: a web server for drawing and auto-annotating plasmid maps. Nucleic Acids Res. 2004, W660-664. 10.1093/nar/gkh410. 32 Web ServerGoogle Scholar
  62. Takagi S, Sasado T, Tamiya G, Ozato K, Wakamatsu Y, Takeshita A, Kimura M: An efficient expression vector for transgenic medaka construction. Mol Mar Biol Biotechnol. 1994, 3 (4): 192-199.PubMedGoogle Scholar
  63. Imamura Y, Ma CL, Pabba M, Bergeron R: Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus. J Neurochem. 2008, 105 (6): 2454-2465. 10.1111/j.1471-4159.2008.05324.x.View ArticlePubMedGoogle Scholar
  64. Myers PZ, Eisen JS, Westerfield M: Development and axonal outgrowth of identified motoneurons in the zebrafish. J Neurosci. 1986, 6 (8): 2278-2289.PubMedGoogle Scholar
  65. Liu DW, Westerfield M: Clustering of muscle acetylcholine receptors requires motoneurons in live embryos, but not in cell culture. J Neurosci. 1992, 12 (5): 1859-1866.PubMedGoogle Scholar
  66. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A: JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008, D102-106. 36 DatabaseGoogle Scholar
  67. Brudno M, Do CB, Cooper GM, Kim MF, Davydov E, Green ED, Sidow A, Batzoglou S: LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res. 2003, 13 (4): 721-731. 10.1101/gr.926603.PubMed CentralView ArticlePubMedGoogle Scholar
  68. Mayor C, Brudno M, Schwartz JR, Poliakov A, Rubin EM, Frazer KA, Pachter LS, Dubchak I: VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics. 2000, 16 (11): 1046-1047. 10.1093/bioinformatics/16.11.1046.View ArticlePubMedGoogle Scholar

Copyright

© Itou et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement